Clinical Trial Update: O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial assessed the combination of O6-Benzylguanine with topical Carmustine in patients with early-stage cutaneous T-cell lymphoma, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• O6-Benzylguanine (O6-Benzylguanine)
• Topical Carmustine (carmustine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-23